* Generation Bio Co GBIO.OQ reported a quarterly adjusted loss
of 56 cents per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 56 cents per share.
* Reported revenue was zero; analysts expected zero.
* Generation Bio Co's reported EPS for the quarter was a loss
of 56 cents.
* The mean earnings estimate of analysts had fallen by
about 2.5% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Generation Bio Co shares had fallen by 14.2% this quarter and
lost 24.2% so far this year.
* The company reported a quarterly loss of $31.86 million.
* Wall Street's median 12-month price target for Generation Bio
Co is $38.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 11 at 12:11 a.m.
All figures in US dollars unless otherwise stated